Literature DB >> 3584221

Photochemotherapy of animal tumors with the photosensitizer methylene blue using a krypton laser.

K König, V Bockhorn, W Dietel, H Schubert.   

Abstract

The cytotoxic effect of the photosensitizer Methylene Blue activated with long wavelength laser radiation has been investigated using mice with solid Ehrlich carcinomas. A krypton laser was used as a light source emitting laser radiation at 647 nm and 676 nm. The red spectral range is important for photochemotherapy because it is easily transmitted through tissue. A significant tumor reduction, including complete tumor destruction, has been achieved.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3584221     DOI： 10.1007/bf00396390

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  5 in total

Review 1.  Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy.

Authors:  D Kessel
Journal:  Photochem Photobiol       Date:  1984-06       Impact factor: 3.421

2.  [Photodynamic effect upon the solid Ehrlich carcinoma].

Authors:  H Berg; W Jungstand
Journal:  Naturwissenschaften       Date:  1966-09

3.  Photoradiation therapy for the treatment of malignant tumors.

Authors:  T J Dougherty; J E Kaufman; A Goldfarb; K R Weishaupt; D Boyle; A Mittleman
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

4.  In vivo staining test with methylene blue for bladder cancer.

Authors:  I Fukui; M Yokokawa; G Mitani; F Ohwada; M Wakui; M Washizuka; T Tohma; K Igarashi; T Yamada
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

5.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer.

Authors:  Y Hayata; H Kato; C Konaka; J Ono; N Takizawa
Journal:  Chest       Date:  1982-03       Impact factor: 9.410
  5 in total
  8 in total

1.  Methylene blue mediated photobiomodulation on human osteoblast cells.

Authors:  Gamze Bölükbaşı Ateş; Ayşe Ak; Bora Garipcan; Murat Gülsoy
Journal:  Lasers Med Sci       Date:  2017-08-04       Impact factor: 3.161

2.  Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils.

Authors:  Masamitsu Tanaka; Manabu Kinoshita; Yasuo Yoshihara; Nariyoshi Shinomiya; Shuhji Seki; Koichi Nemoto; Takahiro Hirayama; Tianhong Dai; Liyi Huang; Michael R Hamblin; Yuji Morimoto
Journal:  Photochem Photobiol       Date:  2011-10-31       Impact factor: 3.421

3.  Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals.

Authors:  Thomas H Foster; Benjamin R Giesselman; Rui Hu; Malcolm E Kenney; Soumya Mitra
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

4.  Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue.

Authors:  Timothy M Baran; Benjamin R Giesselman; Rui Hu; Merrill A Biel; Thomas H Foster
Journal:  Lasers Surg Med       Date:  2010-10       Impact factor: 4.025

Review 5.  Photodynamic therapy induces an immune response against a bacterial pathogen.

Authors:  Ying-Ying Huang; Masamitsu Tanaka; Daniela Vecchio; Maria Garcia-Diaz; Julie Chang; Yuji Morimoto; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

6.  Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers.

Authors:  N Kashef; G Esmaeeli Djavid; M Siroosy; A Taghi Khani; F Hesami Zokai; M Fateh
Journal:  Iran J Microbiol       Date:  2011-03

7.  Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.

Authors:  Masamitsu Tanaka; Pawel Mroz; Tianhong Dai; Liyi Huang; Yuji Morimoto; Manabu Kinoshita; Yasuo Yoshihara; Koichi Nemoto; Nariyoshi Shinomiya; Suhji Seki; Michael R Hamblin
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

8.  Development and Characterization of Methylene Blue Oleate Salt-Loaded Polymeric Nanoparticles and their Potential Application as a Treatment for Glioblastoma.

Authors:  J M Castañeda-Gill; A P Ranjan; J K Vishwanatha
Journal:  J Nanomed Nanotechnol       Date:  2017-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.